U.S. Ambassador Convenes Corporate Leaders, Launches the Mumbai Dialogue: Towards a TB-Free India
USAID Bureau for Global Health sent this bulletin at 10/01/2015 09:00 AM EDT
Join Global Health on
Follow Global Health on
In an historic effort to eradicate
one of the most deadly diseases in India, U.S. Ambassador to India Richard Verma, Bollywood
superstar Amitabh Bachchan, and Sir Ratan Tata, chairman of Tata
Trusts, joined corporate leaders on September 10, 2015, to launch a dialogue
for a tuberculosis-free India.
The "Mumbai
Dialogue: Towards a TB Free India” event highlighted
the plight of tuberculosis (TB) in India and emphasized the need for
public-private partnerships and commitment from all levels of society to turn
the tide against TB in India. According to the
World Health Organization, 240,000 Indians die of TB each year, and
nearly 100,000 suffer from multidrug-resistant TB.
Bachchan, who himself successfully
fought TB, reminded everyone, "As a TB survivor, I can also tell
you that this is a disease that can be fought against and won over." Ambassador Verma called for a "multi-sectoral approach in
which partners, public and private, should collaborate” to end TB.
Over the last 18 years, continued
investment from the U.S. Government in India has resulted in close to $100
million to prevent and control TB, and it has helped to treat over 15
million people. The U.S. Agency for International Development (USAID) has supported numerous initiatives to help
combat TB in India during this time, including critical long-term
technical assistance at national, state, and district levels to support the
Revised National TB Control Program. USAID also supports development and
scale-up of innovative solutions for TB diagnosis and treatment, including a
key demonstration study of GeneXpert® MTB/RIF, the first ever anti-TB drug
resistance survey, and the Grand Challenges in TB Control initiative in partnership with IKP Knowledge Park and the Bill
& Melinda Gates Foundation. The Grand Challenges initiative seeks to
identify, fund, and nurture technology-driven solutions that will assist in
achieving a world free of TB.